CareRx Management
Management criteria checks 1/4
CareRx's CEO is Puneet Khanna, appointed in May 2023, has a tenure of 1.58 years. total yearly compensation is CA$1.30M, comprised of 28.5% salary and 71.5% bonuses, including company stock and options. directly owns 0.011% of the company’s shares, worth €8.84K. The average tenure of the management team and the board of directors is 1.3 years and 3.1 years respectively.
Key information
Puneet Khanna
Chief executive officer
CA$1.3m
Total compensation
| CEO salary percentage | 28.5% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.01% |
| Management average tenure | 1.3yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CA$6m |
| Jun 30 2024 | n/a | n/a | -CA$7m |
| Mar 31 2024 | n/a | n/a | -CA$4m |
| Dec 31 2023 | CA$1m | CA$371k | -CA$5m |
| Sep 30 2023 | n/a | n/a | -CA$6m |
| Jun 30 2023 | n/a | n/a | -CA$7m |
| Mar 31 2023 | n/a | n/a | -CA$34m |
| Dec 31 2022 | CA$733k | CA$261k | -CA$34m |
| Sep 30 2022 | n/a | n/a | -CA$34m |
| Jun 30 2022 | n/a | n/a | -CA$36m |
| Mar 31 2022 | n/a | n/a | -CA$20m |
| Dec 31 2021 | CA$500k | CA$250k | -CA$23m |
| Sep 30 2021 | n/a | n/a | -CA$21m |
| Jun 30 2021 | n/a | n/a | -CA$24m |
| Mar 31 2021 | n/a | n/a | -CA$29m |
| Dec 31 2020 | CA$346k | CA$42k | -CA$18m |
Compensation vs Market: Puneet's total compensation ($USD906.24K) is above average for companies of similar size in the German market ($USD469.36K).
Compensation vs Earnings: Puneet's compensation has increased whilst the company is unprofitable.
CEO
Puneet Khanna
1.6yrs
Tenure
CA$1,302,314
Compensation
Mr. Puneet Khanna has been Chief Executive Officer and President at CareRx Corporation since May 31, 2023 and as its Director since June 06, 2023. He was the Chief Operating Officer at CareRx Corporation f...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.6yrs | CA$1.30m | 0.011% € 8.8k | |
| Senior VP of Corporate Development | 7.3yrs | CA$521.03k | 0.083% € 68.0k | |
| Chief People & Culture Officer | 2.9yrs | CA$551.41k | no data | |
| Senior VP of Western Operations & System Integration | less than a year | CA$461.11k | 1.42% € 1.2m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Vice President of Information Technology | less than a year | no data | no data | |
| Senior Vice President of Operations East & Business Transformation | no data | no data | no data | |
| Vice President of Business Planning & Analysis | no data | no data | 0.033% € 27.2k |
1.3yrs
Average Tenure
Experienced Management: 29C1's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.5yrs | CA$1.30m | 0.011% € 8.8k | |
| Independent Director | 2.7yrs | CA$117.50k | 0.035% € 28.6k | |
| Independent Chairman | 1.5yrs | CA$109.00k | 0.051% € 41.8k | |
| Director | 3.5yrs | CA$90.00k | 0.058% € 47.2k | |
| Director | 5.1yrs | CA$95.00k | no data | |
| Director | 4.6yrs | CA$120.00k | no data |
3.1yrs
Average Tenure
Experienced Board: 29C1's board of directors are considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 16:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CareRx Corporation is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Doug Cooper | Beacon Securities Limited |
| David Martin | Bloom Burton & Co. |
| Prasath Pandurangan | Bloom Burton & Co. |